US Patent Issued to Sichuan University, Nuclear Industry 416 Hospital on Sept. 16 for "Use of compound in preparation of medicament for prophylaxis and treatment of inflammatory tissue damage" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,951, issued on Sept. 16, was assigned to Sichuan University (Chengdu, China) and Nuclear Industry 416 Hospital (Chengdu, China).

"Use of compound in preparation of medicament for prophylaxis and treatment of inflammatory tissue damage" was invented by Shuyu Zhang (Chengdu, China), Fenghao Geng (Chengdu, China), Jianhui Chen (Chengdu, China) and Xiaoqian Li (Chengdu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to use of a compound in preparation of a medicament for prophylaxis and treatment of inflammatory tissue damage. The present disclosure provides use of a compound in preparation of a medicament for proph...